✦ LIBER ✦

O-084 Phase 2 study of bortezomib±docetaxel in advanced non-smallcell lung cancer (NSCLC)

✍ Scribed by Fanucchi, M.; Fossella, F.; Fidias, P.; Natale, R.; Belt, R.; Govindan, R.; Raez, L.; Schiller, J.; Kashala, O.; Kelly, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-196 Concurrent chemo-radiotherapy in l

✍ Bouillet, T.; Diana, C.; Pailler, M.; Gozy, M.; Labrune, S.; Gervais, R.; Brecho 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Phase I study of cisplatin, docetaxel an

✍ Kiura, K; Ueoka, H; Eguchi, K; Segawa, Y; Takigawa, N; Kamei, H; Shibayama, T; H 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Phase I study of docetaxel (DTX) and car

✍ Sawada, M; Kubota, K; Ito, R; Watanabe, H; Akiyama, Y; Kusaba, H; Yamamoto, N; S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Phase 2 study of frontline bortezomib in

✍ Besse, Benjamin; Planchard, David; Veillard, Anne-Sophie; Taillade, Laurent; Kha 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 263 KB

O-222 Gemcitabine-Docetaxel (GD) versus

✍ Pujol, Jean-Louis; Breton, Jean-Luc; Riviere, Alain; Rebattu, Paul; Depierre, Al 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Phase I/II trial of gemcitabine plus doc

✍ Valerie Israel; Scott T. Tagawa; Terry Snyder; Susan Jeffers; Derek Raghavan 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 66 KB